Shifting incidence and survival of epithelial ovarian cancer (1995‐2014): A SurvMark‐2 study - Cabasag - 2023 - International Journal of Cancer - Wiley Online Library
IJMS | Free Full-Text | Strategy for Pre-Clinical Development of Active Targeting MicroRNA Oligonucleotide Therapeutics for Unmet Medical Needs
Frontiers | Association Between Benign Ovarian Tumors and Ovarian Cancer Risk: A Meta-Analysis of Ten Epidemiological Studies
Biomedicines | Free Full-Text | The Role of the Adipokine Resistin in the Pathogenesis and Progression of Epithelial Ovarian Cancer
Frontiers | Pre-diagnosis Cruciferous Vegetables and Isothiocyanates Intake and Ovarian Cancer Survival: A Prospective Cohort Study
Epidemiology of Ovarian Cancer (Chapter 1) - Cancer of the Ovary
Overview of Ovarian Cancer - CancerConnect
Associate Professor Susan Jordan - School of Public Health - University of Queensland
Cancers | Free Full-Text | Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review
Statin use and survival among women with ovarian cancer: an Australian national data-linkage study | British Journal of Cancer
Ovarian Cancer Immunotherapy en Route: IL9 Inhibits Growth of Ovarian Cancer and Upregulates its Expression of Ox40L and 4-1BBL
Frontiers | Identification of NAD+ Metabolism-Derived Gene Signatures in Ovarian Cancer Prognosis and Immunotherapy
RNA epigenetic modifications in ovarian cancer: The changes, chances, and challenges - Ye - WIREs RNA - Wiley Online Library
Medicina | Free Full-Text | Progression Free Survival, Overall Survival, and Relapse Rate in Endometrioid Ovarian Cancer and Synchronous Endometrial- Ovarian Endometrioid Cancer (SEO-EC): Results from a Large Retrospective Analysis
Targeted Detection of Cyclooxygenase-1 in Ovarian Cancer | ACS Medicinal Chemistry Letters
Cancers | Free Full-Text | Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study
Epidemiology of epithelial ovarian cancer - ScienceDirect
IJMS | Free Full-Text | Gene Expression Indicates Altered Immune Modulation and Signaling Pathway Activation in Ovarian Cancer Patients Resistant to Topotecan
Cancers | Free Full-Text | An Overview of Candidate Therapeutic Target Genes in Ovarian Cancer
Frontiers | Tumor Microenvironment in Ovarian Cancer: Function and Therapeutic Strategy
PDF) The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer
Bibliometric analysis of hotspots and frontiers in cancer-related fatigue among ovarian cancer survivors | PLOS ONE
Cells | Free Full-Text | Hereditary Ovarian Carcinoma: Cancer Pathogenesis Looking beyond BRCA1 and BRCA2
A machine learning approach to identify predictive molecular markers for cisplatin chemosensitivity following surgical resection in ovarian cancer | Scientific Reports
Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium | British Journal of Cancer
Bibliometric analysis of hotspots and frontiers in cancer-related fatigue among ovarian cancer survivors | PLOS ONE
